Genesis Research, LLC
San Diego, California 92123
0 studies enrolling now · 15 studies all time
What they study most
Advanced Prostate Adenocarcinoma, Benign Prostatic Hyperplasia, Bladder Cancer, Cystitis, Interstitial, Erectile Dysfunction, Hematuria, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen, Overactive Bladder, Painful Bladder Syndrome, Prostate Cancer, Prostatic Neoplasms, Secondary Hypogonadism
Studies at this site
- Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer — Recruiting now
- A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
- Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
- A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer — Running, not enrolling
- Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging — Stopped early
- To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer — Stopped early
- Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg — Completed
- UroLift System TOlerability and ReCovery When Administering Local Anesthesia — Completed
- Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma — Completed
- 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment — Completed
- The Safety and Effectiveness of UroLift: LIFT Pivotal Study — Completed
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study — Stopped early
- A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed
- OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
- Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men — Status unconfirmed